Table 2.
Clinical characteristics and HLA genotype in patients with type 1 diabetes and nondiabetic control subjects.
| Case No. Patients |
Age (years) |
Sex | T1D Duration (months) |
DR Genotype |
|---|---|---|---|---|
| 1 | 16 | F | 304 | x/4 |
| 2 | 28 | F | 145 | 4/8 |
| 3 | 19 | F | 2 | 4/6 |
| 4 | 39 | F | 373 | 4/5 |
| 5 | 9 | F | 30 | 3/4 |
| 6 | 14 | M | 30 | 1/4 |
| 7 | 23 | F | 40 | 3/4 |
| 8 | 15 | M | 30 | 4/4 |
| 9 | 20 | F | 9 | 3/4 |
| 10 | 9 | F | 6 | 4/4 |
| 11 | 10 | M | 11 | 3/4 |
| 12 | 16 | M | 18 | 3/4 |
| 13 | 20 | M | 42 | 4/7 |
| 14 | 17 | M | 0 | 1/4 |
| Control Subjects | ||||
| C1 | 37 | F | - | 4/5 |
| C2 | 20 | M | - | 1/4 |
| C3 | 17 | F | - | 4/7 |
| C4 | 36 | F | - | 4/4 |
| C5 | 20 | F | - | 1/4 |
| C6 | 18 | F | - | 1/4 |
| C7 | 32 | F | - | 4/4 |
| C8 | 25 | F | - | 4/4 |
*
T1D = type 1 diabetes; DQ8 is part of the DR4 haplotype; x = unable to obtain complete DR genotype.